| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
| mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0018 |
1 |
| mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
1 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.0016 |
1 |
| mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |